Insiders Teva Pharmaceutical Industries Ltd (ADR) Nasdaq

Equities

US8816242098

Real-time Estimate Cboe BZX Other stock markets 10:41:59 2024-05-16 am EDT			5-day change	1st Jan Change
16.54 ^USD	0.00%		0.00%	0.00%

May. 15	Teva Pharmaceutical Industries Insider Sold Shares Worth $254,807, According to a Recent SEC Filing	MT
May. 15	Teva Pharmaceutical Industries Limited Announces Management Changes, Effective June 3, 2024	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Teva Pharmaceutical Industries Insider Sold Shares Worth $254,807, According to a Recent SEC Filing	May. 15	MT
Teva Pharmaceutical Industries Limited Announces Management Changes, Effective June 3, 2024	May. 15	CI
Teva Pharmaceutical Industries Insider Sold Shares Worth $657,240, According to a Recent SEC Filing	Mar. 07	MT
Teva Pharmaceutical Industries Insider Sold Shares Worth $1,048,119, According to a Recent SEC Filing	Mar. 07	MT
Teva Pharmaceutical Industries Insider Sold Shares Worth $1,352,090, According to a Recent SEC Filing	Mar. 07	MT
Teva Pharmaceutical Industries Insider Sold Shares Worth $414,270, According to a Recent SEC Filing	Mar. 05	MT
Teva Pharmaceutical Industries Insider Sold Shares Worth $1,277,207, According to a Recent SEC Filing	Mar. 05	MT
Teva Pharmaceutical Industries Insider Sold Shares Worth $270,176, According to a Recent SEC Filing	Mar. 01	MT
Teva Pharmaceutical Industries Ltd. Appoints R. Ananthanarayanan as CEO of Its Teva Active Pharmaceutical Ingredients Business	Nov. 07	CI
Teva Announces Changes to Executive Management Team	23-09-28	CI
Insider Sell: Teva Pharmaceutical Industries	23-08-09	MT
Insider Sell: Teva Pharmaceutical Industries	23-08-03	MT
Teva Pharmaceutical Industries Limited Appoints Varda Shalev as Member of the Board, Effective September 1, 2023	23-08-02	CI
INTERVIEW - Richard Francis, CEO of Teva Pharmaceutical: solid quarter, full-year forecasts raised	23-08-02	MT
Teva Announces Appointment of Dr. Angus Grant to Executive Vice President, Business Development, Effective August 1, 2023	23-07-27	CI
Jean-Michel Halfon to Resign from Board of Directors of Teva Pharmaceutical Industries Limited	23-05-11	CI
Insider Sell: Teva Pharmaceutical Industries	23-03-08	MT
Insider Sell: Teva Pharmaceutical Industries	23-03-08	MT
Insider Sell: Teva Pharmaceutical Industries	23-03-08	MT
Insider Sell: Teva Pharmaceutical Industries	23-03-02	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Teva Pharmaceutical Industries isn't out of the woods yet

February 01, 2024 at 04:41 am EST

INTERVIEW - Richard Francis, CEO of Teva Pharmaceutical: solid quarter, full-year forecasts raised

August 02, 2023 at 03:19 pm EDT